share_log

Piper Sandler Reiterates Overweight on Pulmonx, Maintains $17 Price Target

Moomoo 24/7 ·  Apr 3 12:05

Piper Sandler analyst Jason Bednar reiterates Pulmonx (NASDAQ:LUNG) with a Overweight and maintains $17 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment